Core Scientific's AMD Buildout Supports a Cautious Buy

By Rebecca Stone

Core Scientific has 1,120 MW under contract, which the source says could generate $1.6 billion in annual net operating income. That contracted base, together with major contracts involving CoreWeave and AMD, supports the source's cautious Buy rating on CORZ and its $20-per-share valuation.

What does AMD add?

AMD has reserved rights to an additional 1,925 MW. That is a major conditional element of the case, not 1,925 MW of confirmed operating or contracted capacity. The source explicitly identifies AMD's failure to exercise the reservation as a key risk.

The distinction sets the boundary between what Core Scientific has secured and what it could win. The source does not provide a customer-by-customer allocation of the contracted 1,120 MW, an exercise timetable for the AMD reservation, or a contractual price tied to that option. It also does not state when the $1.6 billion annual NOI estimate would begin.

What does the $20 valuation assume?

The $20-per-share figure is the analyst's valuation; the 1,120 MW is the source's contracted figure. The source does not say that all of that capacity already operates. The $1.6 billion is a potential annual NOI outcome associated with the contracted capacity, not booked revenue.

Together with contracts with CoreWeave and AMD, those numbers support the cautious Buy label rather than a more forceful recommendation. This is also not a case that rests only on future reservations. Core Scientific has 1,120 MW under contract. Yet the source's own framing leaves room for caution: AMD may not exercise the additional 1,925 MW, power infrastructure may not be ready on schedule, and financing may cost more than expected.

How will the AMD buildout be funded?

The buildout carries $4.4 billion in commitments. The stated funding plan calls for project bonds or debt rather than equity. In practical terms, that plan avoids making new equity the named funding source for the AMD project while placing the burden on project-level borrowing and its terms.

The source presents project bonds or debt as a plan, not a completed financing; it gives no interest rate, tenor or draw schedule. It also does not identify which portion of the $4.4 billion belongs to each contract or buildout phase. Those omissions matter because high-cost financing is one of the three risks the analyst explicitly identifies.

What could break the case?

Three failures would weaken the thesis. First, AMD could leave the reserved 1,925 MW unused, reducing the expansion upside beyond the contracted base. Second, delays in electricity infrastructure could interrupt the path from available capacity to operating capacity and the projected $1.6 billion annual NOI.

Third, expensive project financing could reduce returns on the $4.4 billion commitment even if construction and commercial operations proceed as planned. The source does not quantify that risk, so it should not be read as a forecast of a specific default, cancellation or financing failure. It is a stated sensitivity around the cost of capital.

The commercial logic remains straightforward. Contracted megawatts provide the base case; reserved megawatts provide potential expansion; the $4.4 billion commitment sets the capital requirement.

If AMD converts its rights and Core Scientific funds and connects the buildout without major delays, the analyst's $20 valuation has more support. If any of those conditions fail, the contracted 1,120 MW remains the more dependable part of the case.

What are the disclosure limits?

The source analyst disclosed: "I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours."

The analyst also said they wrote the article themselves and expressed their own views, received no compensation other than from Seeking Alpha, and had no business relationship with any company whose stock is mentioned.

Seeking Alpha added its own warning: "Past performance is no guarantee of future results." The platform said no recommendation or advice was being given on whether the investment was suitable for a particular investor and that the analyst's views might not reflect Seeking Alpha as a whole.

It also said Seeking Alpha is not a licensed securities dealer, broker, US investment adviser or investment bank. Its third-party analysts include professional and individual investors who may lack licenses or certifications from an institute or regulatory body. That disclosure framework leaves the investment case with the analyst's assumptions and estimates, not a guarantee from the platform.

The next test is whether AMD exercises its rights to the additional 1,925 MW; until then, the 1,120 MW under contract anchors the cautious case, while infrastructure delays and costly debt could constrain returns.